跳至主要内容
临床试验/ISRCTN66148745
ISRCTN66148745已完成4 期

A randomised, double-blind, placebo-controlled trial of metformin in chronic obstructive pulmonary disease (COPD) exacerbations: a pilot study evaluating anti-hyperglycaemic efficacy

St George's, University of London (UK)0 个研究点目标入组 69 人开始时间: 2011年3月17日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
69

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Current inclusion criteria as of 06/03/2014:
  • 1. Pre-existing diagnosis of COPD
  • 2. Admission to hospital principally for an exacerbation of COPD
  • 3. Aged greater than or equal to 35 years
  • 4. Expected to remain in hospital for =48 hours
  • Previous inclusion criteria:
  • 1. Pre-existing diagnosis of COPD
  • 2. Admission to hospital principally for an exacerbation of COPD
  • 3. Aged greater than or equal to 35 years
  • 4. Able to enter the study within 48 hours of admission

排除标准

  • 1. Prior diagnosis of diabetes mellitus requiring insulin or oral hypoglycaemic therapy
  • 2. Hypersensitivity to metformin hydrochloride or to any of the excipients
  • 3. Renal impairment
  • 4. Severe sepsis
  • 5. Metabolic acidosis
  • 6. Decompensated type 2 respiratory failure
  • 7. Severe congestive cardiac failure
  • 8. Acute coronary syndrome
  • 9. Hepatic insufficiency
  • 10. Excessive alcohol consumption
  • 11. Malnourished or at high risk for malnutrition
  • 12. Moribund or not for active treatment
  • 13. Admitted to critical care unit
  • 14. Unable to give informed consent
  • 15. Pregnancy or lactation

研究者

发起方
St George's, University of London (UK)

相似试验

进行中(未招募)
不适用
A study to evaluate the potency, quality of life, side effects and tolerability of long-term treatment (24 weeks) with prucalopride in patients aged =18 years with chronic constipation.Chronic constipationMedDRA version: 14.1Level: PTClassification code 10010774Term: ConstipationSystem Organ Class: 10017947 - Gastrointestinal disorders
EUCTR2011-000670-62-HUShire-Movetis NV360
尚未招募
不适用
A randomised control trial of the effect of Niacinamide on Fibroblast Growth factor 23 (FGF23) levels in Chronic Kidney Disease.
ACTRN12613001229763Christopher Hood90
已完成
不适用
The efficacy of treatment with St John?s Wort for premenstrual syndrome (PMS)Pre-menstrual syndrome (PMS)Urological and Genital DiseasesPain and other conditions associated with female genital organs and menstrual cycle
ISRCTN31487459niversity of Leeds (UK)41
已完成
3 期
IMPROVE: IMpact of Phosphate Reduction On Vascular End-points in Chronic Kidney DiseasePhosphate imbalance (as a risk factor for cardiovascular disease) in patients with Chronic Kidney DiseaseRenal and Urogenital - Kidney diseaseCardiovascular - Diseases of the vasculature and circulation including the lymphatic system
ACTRN12610000650099Australasian Kidney Trials Network (University of Qld)278
进行中(未招募)
1 期
Erythropoietin in TraumaTraumatic InjuryMedDRA version: 23.1Level: SOCClassification code 10022117Term: Injury, poisoning and procedural complicationsSystem Organ Class: 10022117 - Injury, poisoning and procedural complications
EUCTR2020-003388-24-SIniversity College Dublin2,500
Metformin in chronic obstructive pulmonary disease | 临床试验